steve usdin

@steveusdin1

Washington Editor, BioCentury. Author: Bureau of Spies & Engineering Communism.

Vrijeme pridruživanja: rujan 2011.

Tweetovi

Blokirali ste korisnika/cu @steveusdin1

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @steveusdin1

  1. prije 38 minuta

    An elegant explanation of an important study by the founder of Immuno-oncology - Steve Rosenberg. He has found a way to make T cell therapies by taking T cells from blood rather than from tumors, which is far less invasive.

    Poništi
  2. prije 1 sat

    GlaxoSmithKline to make its immune-boosting adjuvant technology available to #2019-nCoV vaccine makers. This will dramatically stretch supplies and could make vaccines more effective. The agreement covers 4 groups making vaccines funded by CEPI.

    Poništi
  3. proslijedio/la je Tweet
    prije 9 sati

    GSK to provide adjuvant to boost effectiveness and stretch supplies of vaccines

    Poništi
  4. 1. velj

    Another thing to consider re #2019-nCoV: China has become integrated into global drug development. China in general, and Wuhan in particular, are the sites of many drug trials. These aren't likely to priorities in a public health emergency.

    Poništi
  5. proslijedio/la je Tweet
    1. velj

    I'm excited to join this March 24 workshop on digital health as a new member of 's Forum on Drug Discovery, Development, and Translation. The workshop is open to the public! Details below:

    Poništi
  6. 31. sij

    HHS declares #2019-nCoV a public health emergency. Separate declarations will be needed to allow FDA to issue Emergency Use Authorizations (EUAs), e.g., for use of unapproved diagnostics.

    Poništi
  7. 31. sij

    A dozen #2019-nCoV vaccine development programs have been announced, five efforts to discover and develop therapeutic antibodies.

    Poništi
  8. 31. sij
    Poništi
  9. 29. sij

    DARPA-funded AbCellera to develop mAbs to treat coronavirus outbreak. This is the third company to announce it is developing antibodies for the Wuhan 2019-nCoV outbreak.

    Poništi
  10. 29. sij

    Harvard chemistry chair arrested, accused of lying about China ties. Separately, Yanqing Ye was charged with conducting research and sending U.S. documents and information to China while studying in Boston University.

    Poništi
  11. proslijedio/la je Tweet
    28. sij

    One class act is this ! We hand her off to PwC with the warmest of wishes, knowing she will excel there as she does everywhere. She leaves a great legacy , and will extend her leadership, covering now translation to clin dev.

    Poništi
  12. 28. sij

    J&J developing (#2019-nCoV) coronavirus vaccine, at least nine other vaccines under development. J&J brings a great deal of expertise, experience, resources. But the first Ebola vaccine came from an academic lab.

    Poništi
  13. proslijedio/la je Tweet
    27. sij

    Mike Bloomberg wants to set a limit of one 20-year patent per drug

    Poništi
  14. proslijedio/la je Tweet
    27. sij

    Chief Scientific Officer Dr Paul Stoffels told us this AM on the co started working on vaccine 2 wks ago

    Prikaži ovu nit
    Poništi
  15. 26. sij

    At least 8 #2019-nCoV vaccines under development using a variety of technologies. List below. In addition at least three groups are working on mAbs: Regeneron, Vir, and NIH’s NIAID. mAbs might be ready faster and provide both prophylaxis and treatment.

    Poništi
  16. proslijedio/la je Tweet
    25. sij

    MOBS Lab: Preliminary analysis of the 2019 nCOV outbreak in city / visualization of cases and estimates of risk of exportation to different countries using travel patterns

    Poništi
  17. 25. sij

    Publication of the gene sequence of the Wuhan coronavirus has sparked a race to develop vaccines and drugs. The first could be monoclonal antibodies that are both treatment and prophylaxis.

    Poništi
  18. proslijedio/la je Tweet

    . Francis Collins gets out his crystal ball and looks ahead to 2020 in this nice interview with Karen Tkach Tuzman of :

    Poništi
  19. 24. sij

    Biopharma companies, academics, governments racing to develop medical countermeasures against novel coronavirus. At least 7 vaccines already under development against .

    Poništi
  20. 23. sij

    At least 7 vaccines under development for Wuhan coronavirus. For those that get to and through Phase I trials, will there be funding for Phase II? Will the outbreak burn out before a vaccine is ready for Phase II testing (like Zika and SARS)?

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·